Predicting the Role of DNA Polymerase β Alone or with KRAS Mutations in Advanced NSCLC Patients Receiving Platinum-Based Chemotherapy

Clinical data suggest that only a subgroup of non-small cell lung cancer (NSCLC) patients has long-term benefits after front-line platinum-based therapy. We prospectively investigate whether KRAS status and DNA polymerase β expression could help identify patients responding to platinum compounds. Pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Alvisi, Maria Francesca, Ganzinelli, Monica, Linardou, Helena, Caiola, Elisa, Lo Russo, Giuseppe, Cecere, Fabiana Letizia, Bettini, Anna Cecilia, Psyrri, Amanda, Milella, Michele, Rulli, Eliana, Fabbri, Alessandra, De Maglie, Marcella, Romanelli, Pierpaolo, Murray, Samuel, Ndembe, Gloriana, Broggini, Massimo, Garassino, Marina Chiara, Marabese, Mirko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465625/
https://www.ncbi.nlm.nih.gov/pubmed/32751518
http://dx.doi.org/10.3390/jcm9082438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465625/
https://www.ncbi.nlm.nih.gov/pubmed/32751518
http://dx.doi.org/10.3390/jcm9082438

Ejemplares similares